GlassScriptPhysician profile
Paul P Weitzel
NPI 1235197872
$5,630.18
in general payments reported to CMS, 2019-2025
17 companies · $628 in 2025
The $628 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,598 · 2020: $1,933 · 2021: $14.22 · 2022: $402 · 2023: $558 · 2024: $498 · 2025: $628.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $3,459.38 | 2019-2022 | |
| Smith+Nephew, INC. | $425.47 | 2020-2025 | Na, N/A, Real Intelligence |
| Exactech, INC. | $280.16 | 2022-2024 | |
| Pacira Pharmaceuticals Incorporated | $229.34 | 2022 | |
| Stryker Corporation | $213.27 | 2025 | Mako |
| Kairos Surgical INC | $194.22 | 2024 | |
| Linvatec Corporation | $185.11 | 2023 | Biobrace 23mm |
| Osteoremedies, LLC | $170.66 | 2025 | Biowash Surgical Irrigation, Remedy Spacer, Osteoboost Select 5cc |
| Vertex Pharmaceuticals Incorporated | $138.14 | 2025 | |
| Heron Therapeutics, INC. | $104.14 | 2024 | Zynrelef |
| Depuy Synthes Sales INC. | $57.15 | 2024-2025 | Monovisc, Orthovisc |
| Vericel Corporation | $51.16 | 2021-2023 | Maci |
| Medical Device Business Services, INC. | $36.54 | 2019 | |
| Integra Lifesciences Corporation | $27.27 | 2024 | Instruments-Orthopedic, Integra Duo, Integra |
| Bioventus LLC | $22.06 | 2023 | Exogen Ultrasound Bone Healing System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $20.33 | 2025 | Cios Flow |
| Biomerieux INC | $15.78 | 2023 | Filmarray 2.0 Instrument |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Weitzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.